Real-world treatment persistence of non-tumor necrosis factor inhibitors versus tumor necrosis factor inhibitors among patients with rheumatoid arthritis in South Korea-Reference-Cited by-同舟云学术

Real-world treatment persistence of non-tumor necrosis factor inhibitors versus tumor necrosis factor inhibitors among patients with rheumatoid arthritis in South Korea

Published:2019-11-18 Issue:2 Volume:36 Page:343-351
ISSN:0300-7995
Container-title:Current Medical Research and Opinion
language:en
Short-container-title:Current Medical Research and Opinion

Author:

Park Jae-A¹^ORCID,Lee Min-Young²,Nam Jin Hyun³^ORCID,Shin Ju-Young¹,Wood Robert⁴,Holbrook Tim⁴,Kwon Sun-Hong¹^ORCID

Affiliation:

1. School of Pharmacy, Sungkyunkwan University, Suwon, South Korea;

2. VIAplus, Siheung, South Korea;

3. Department of Public Health Sciences, Medical University of South Carolina, Charleston, SC, USA;

4. Real-World Evidence Generation, Adelphi Real World, Bollington, UK

Publisher

Informa UK Limited

Subject

General Medicine

Link

https://www.tandfonline.com/doi/pdf/10.1080/03007995.2019.1688271

Reference35 articles.

1. 2015 American College of Rheumatology Guideline for the Treatment of Rheumatoid Arthritis

2. Switching of biologic disease modifying anti-rheumatic drugs in patients with rheumatoid arthritis in a real world setting

3. Persistence of biologic disease-modifying antirheumatic drugs in patients with rheumatoid arthritis: An analysis of the South Korean National Health Insurance Database

4. EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2013 update

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Actualización del Documento de Consenso de la Sociedad Española de Reumatología sobre el uso de terapias biológicas y sintéticas dirigidas en la artritis reumatoide;Reumatología Clínica;2024-07

2. Drug Persistence and Incidence of Active Tuberculosis of Tumor Necrosis Factor Alpha Inhibitors Versus Tocilizumab as the First-Line Biological Treatment in Patients with Rheumatoid Arthritis: A Nationwide Population-Based Retrospective Cohort Analysis;Rheumatology and Therapy;2024-05-20

3. Real-world Comparative Effectiveness of Methotrexate-based Combinations for Rheumatoid Arthritis: A Retrospective Cohort Study;Clinical Therapeutics;2023-09

4. Summarizing current refractory disease definitions in rheumatoid arthritis and polyarticular juvenile idiopathic arthritis: systematic review;Rheumatology;2021-03-12

5. Outcomes in rheumatoid arthritis patients treated with abatacept: a UK multi-centre observational study;BMC Rheumatology;2021-02-04